Table 1 Baseline characteristics of the study subjects.
From: Association of serum bilirubin levels with risk of cancer development and total death
Total | Men | Women | |
|---|---|---|---|
No | 29,080 | 12,946 | 16,134 |
Follow-up time, years | 4.7 (2.4–7.9) | 4.6 (2.3–7.7) | 4.8 (2.5–8.0) |
Age, years | 52 (37–62) | 55 (42–63) | 49 (34–60) |
Body mass index, kg/m2 | 23.0 (4.2) (n = 28,105) | 23.7 (3.8) (n = 12,532) | 22.4 (4.3) (n = 15,573) |
Bilirubin, mg/dL | 0.65 (0.50–0.82) | 0.70 (0.54–0.90) | 0.60 (0.50–0.80) |
Smoking, yes | 8301(31.8%) (n = 26,144) | 6021 (52.0%) (n = 11,576) | 2280 (15.7%) (n = 14,568) |
Diabetes, yes | 5120 (17.6%) | 2958 (22.8%) | 2162 (13.4%) |
Incidence case No | |||
Lung cancer | 403 | 247 | 156 |
Colon cancer | 315 | 173 | 142 |
Breast cancer | 275 | 9 | 266 |
Prostate cancer | 269 | 269 | – |
Cervical cancer | 104 | – | 104 |
Total all-cause death | 331 | 212 | 119 |
